ConductScience.org, home

Paper · 36959359

Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.

Thrift AP and 2 others. Nat Rev Clin Oncol, 2023. Cited by 706 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Papers, record 36959359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959359

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.
PubMed
Journal
Nat Rev Clin Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
706
iCite
Relative citation ratio, by iCite
79
iCite
Revised in PubMed
2026-10-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thrift APAaron P
2Wenker TNTheresa Nguyenhttps://orcid.org/0000-0002-4021-9774
3El-Serag HBHashem Bhttps://orcid.org/0000-0001-5964-7579

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stomach NeoplasmsMajor topic
Helicobacter InfectionsMajor topic
Helicobacter pyloriMajor topic
Humans
Early Detection of Cancer
Risk Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07565857Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal CancerBackground

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References147

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,285,078Tobacco smoke and involuntary smoking.IARC Monogr Eval Carcinog Risks Hum2004https://conductscience.org/library/papers/15285078PubMed
234,183,534The association between diabetes and gastric cancer: results from the Stomach Cancer Pooling Project Consortium.Eur J Cancer Prev2022https://conductscience.org/library/papers/34183534PubMed
335,610,368Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.Br J Cancer2022https://conductscience.org/library/papers/35610368PubMed
428,430,644Red and processed meat consumption and gastric cancer risk: a systematic review and meta-analysis.Oncotarget2017https://conductscience.org/library/papers/28430644PubMed
511,556,297Helicobacter pylori infection and the development of gastric cancer.N Engl J Med2001https://conductscience.org/library/papers/11556297PubMed
624,618,998Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.Cancer Epidemiol Biomarkers Prev2014https://conductscience.org/library/papers/24618998PubMed
727,560,662Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project.Eur J Cancer Prev2018https://conductscience.org/library/papers/27560662PubMed
821,917,738Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.Ann Oncol2012https://conductscience.org/library/papers/21917738PubMed
921,918,974Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go.Int J Cancer2012https://conductscience.org/library/papers/21918974PubMed
1031,654,635Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.Gastroenterology2020https://conductscience.org/library/papers/31654635PubMed

Cited by544

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 706 citations.

PMIDTitleJournalYearIn PapersSource
42,983,403
Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis.
BMC Med2026https://conductscience.org/library/papers/42983403PubMed
42,979,122Activation of KIF18B-MYC axis by autophagic CUL3 degradation promotes copper imbalance essential for gastric cancer progression.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979122PubMed
42,978,691Association between CISD2 expression and clinicopathological features and prognosis in gastric cancer: a systematic review, meta-analysis, and database validation.Front Oncol2026https://conductscience.org/library/papers/42978691PubMed
42,972,272Senescence-related immunosuppressive gene MFAP2 orchestrates stromal-immune crosstalk and immunotherapy resistance in gastric cancer.BMC Cancer2026https://conductscience.org/library/papers/42972272PubMed
42,963,802Evolution and function of genetic polymorphisms in the Helicobacter pylori type IV secretion pilus protein CagL in gastric carcinogenesis.Cell Commun Signal2026https://conductscience.org/library/papers/42963802PubMed
42,963,742Impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer: an evidence synthesis and quantitative analysis.BMC Cancer2026https://conductscience.org/library/papers/42963742PubMed
42,959,646Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management.MedComm (2020)2026https://conductscience.org/library/papers/42959646PubMed
42,953,429Divergent Trends and Widening Inequalities in Digestive Tract Cancers Among Women of Childbearing Age: A Global Analysis from 1990 to 2021 and Projections to 2050.Int J Womens Health2026https://conductscience.org/library/papers/42953429PubMed
42,935,486Micro- and nanoplastics in gastric cancer: A narrative review.Toxicol Rep2026https://conductscience.org/library/papers/42935486PubMed
42,934,272Stabilization of LTBP2 by SIRT1 promotes EMT and chemosensitivity in cardia gastric adenocarcinoma through TGF-β signaling.Oncogene2026https://conductscience.org/library/papers/42934272PubMed

1 to 10 of 544

See all 544 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36959359

GET https://conductscience.org/api/papers/v1/36959359/references?page=2